Rhabdomyosarcoma 2026: Advancing Science, Improving Outcomes, jointly presented by the Departments of Pediatrics and Surgery at Memorial Sloan Kettering Cancer Center (MSK), will take place on 19 October 2026, from 8:30 a.m. to 5:30 p.m., at the Zuckerman Research Center in New York City, with in-person, virtual, and on-demand participation options.

The one-day symposium will focus on multidisciplinary rhabdomyosarcoma care, including advances in medical treatment, surgical techniques for primary and metastatic disease, diagnostic imaging, translational research, and the experiences of patients and families. It is designed for physicians, advanced practice providers, nurses, allied health professionals, and trainees involved in pediatric oncology. Registration costs $299 for physicians, $249 for advanced practice providers, $199 for nurses and other healthcare professionals, $100 for residents and fellows, and $525 for industry professionals; MSK employees may attend free of charge.